Edgestream Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.12M | Buy |
129,560
+68,928
| +114% | +$3.79M | 0.2% | 186 |
|
|
2025
Q1 | $4.29M | Sell |
60,632
-84,364
| -58% | -$5.96M | 0.15% | 275 |
|
|
2024
Q4 | $9.53M | Buy |
144,996
+116,434
| +408% | +$7.65M | 0.41% | 16 |
|
|
2024
Q3 | $2.01M | Buy |
+28,562
| New | +$2.01M | 0.09% | 401 |
|
|
2024
Q2 | – | Sell |
-19,678
| Closed | -$1.72M | – | 858 |
|
|
2024
Q1 | $1.72M | Buy |
+19,678
| New | +$1.72M | 0.09% | 369 |
|
|
2023
Q3 | – | Sell |
-9,180
| Closed | -$796K | – | 822 |
|
|
2023
Q2 | $796K | Sell |
9,180
-3,429
| -27% | -$297K | 0.07% | 409 |
|
|
2023
Q1 | $1.23M | Buy |
+12,609
| New | +$1.23M | 0.14% | 246 |
|
|
2022
Q4 | – | Sell |
-3,026
| Closed | -$257K | – | 512 |
|
|
2022
Q3 | $257K | Sell |
3,026
-1,560
| -34% | -$132K | 0.02% | 411 |
|
|
2022
Q2 | $380K | Sell |
4,586
-12,115
| -73% | -$1M | 0.03% | 433 |
|
|
2022
Q1 | $1.29M | Buy |
+16,701
| New | +$1.29M | 0.1% | 287 |
|